NCT03883711Recruiting
Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation
Acute Myocardial Infarction From Clinical Presentation to Strategy Treatment
Source: ClinicalTrials.gov · Last updated 30 Jan 2026
Brief summary (registry, in English)
AMIPE is both a retrospective and prospective study which was designed in order to collect data of patients with acute coronary syndromes and myocardial injury and to improve the knowledge about these conditions.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 11000 (estimated)
- First submitted
- 15 Mar 2019
- Start date
- 1 Jan 2017
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Coronary artery disease
- NCT number
- NCT03883711
What you commit to
- Study type: Observational
- Planned participants: 11000
- From 1 Jan 2017 to the primary completion date, 31 Dec 2024
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- under age or not able to give informed consent
Who the study is looking for
- Patient aged \> 18 years old
- Acute coronary syndrome or myocardial injury
- Written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Policlinico Sant'Orsola-Malpighi, Cardiology Department Coordinator of this site? Confirm its status | Bologna | Italy | Recruiting |
| Ospedale Maggiore Carlo Alberto Pizzardi Coordinator of this site? Confirm its status | Bologna | Italy | Recruiting |
| Ospedale Morgagni - Pierantoni Coordinator of this site? Confirm its status | Forlì | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.